AI Tool Revolutionizes Prostate Cancer Treatment: Predicts Success of Focal Therapy

AI Tool Improves Prostate Cancer Treatment Outcomes

A groundbreaking study led by UCLA researchers has revealed that artificial intelligence (AI) could significantly enhance treatment outcomes for men with prostate cancer. The study, published in BJUI Compass, focuses on an AI tool called Unfold AI, developed collaboratively by UCLA and Avenda Health 1

1

2

3

Unfold AI: Precision in Tumor Volume Estimation

Unfold AI analyzes data from MRI scans and biopsies to create a detailed, three-dimensional map of prostate tumors. This innovative approach allows doctors to more accurately visualize the true size and boundaries of cancerous growths, addressing a critical limitation in current methods that often underestimate tumor size 1

1

2

3

Dr. Wayne Brisbane, the study's lead author, emphasized the tool's potential: "By using AI to measure the size of a man's prostate tumor more precisely, we can better predict who is likely to be cured with focal therapies like partial gland cryoablation" 1

1

2

3

Clinical Trial Results

The research team conducted a clinical trial involving 204 men with localized prostate cancer who underwent partial gland cryoablation at UCLA between 2017 and 2022. Key findings include:

1. Tumor volume emerged as the strongest predictor of treatment success, surpassing traditional indicators like tumor grade and PSA levels 1

   1

   2

   2

   3

   3

   .
2. Patients with tumors smaller than 1.5 cubic centimeters showed significantly better outcomes after cryotherapy 1

   1

   2

   2

   3

   3

   .
3. Using the 1.5 cubic centimeter tumor volume threshold as an eligibility criterion could have prevented 72% of treatment failures 1

   1

   2

   2

   3

   3

   .

Related Stories

AI Model Shows Promise in Assessing Prostate Cancer Aggressiveness and Guiding Treatment

AI Enhances Prostate Cancer Risk Classification and Outcome Prediction

AI Outperforms Doctors in Prostate Cancer Detection, UCLA Study Reveals

AI Tool Developed by Mount Sinai Researchers Poised to Revolutionize Prostate Cancer Care

Implications for Prostate Cancer Treatment

The study suggests that integrating Unfold AI into treatment decision-making could lead to more personalized prostate cancer care. Dr. Leonard Marks, senior author of the study, noted, "Using AI to predict tumor volume and shape gives a clearer picture and could help choose better candidates for focal cryotherapy" 1

1

2

3

Partial gland cryoablation, a minimally invasive procedure that freezes and destroys only the cancerous part of the prostate, offers several advantages over traditional treatments:

1. Minimizes damage to vital areas surrounding the prostate
2. Results in fewer side effects compared to surgery or radiation
3. Offers patients a better quality of life post-treatment 1

   1

   2

   2

   3

   3

Future Directions and Limitations

While the results are promising, the researchers emphasize the need for larger, multi-center trials to confirm their findings. The study marks an important step in integrating AI into prostate cancer treatment, potentially reducing treatment failures by more than 70% 1

1

2

3

The development of Unfold AI was supported by grants from the National Institutes of Health, highlighting the importance of continued investment in AI-driven medical research 1

1

2

3